Fertility problems: assessment and treatment

Give people who are considering ovulation induction or ovarian stimulation up-to-date information about the long-term health outcomes of these treatments. [2013]

Inform people who are offered ovulation induction or ovarian stimulation that:

• no direct association has been found between these treatments and invasive cancer and

• no association has been found in the short to medium term between these treatments and adverse outcomes (including cancer) in children born from ovulation induction and

• information about long-term health outcomes is still awaited. [2013]

Limit the use of ovulation induction or ovarian stimulation agents to the lowest effective dose and duration of use. [2013]

Give people who are considering IVF treatment, with or without intracytoplasmic sperm injection (ICSI), up to-date information about the long-term health outcomes (including the consequences of multiple pregnancy) of these treatments. [2013]

Inform people that, while the absolute risks of long-term adverse outcomes of IVF treatment, with or without ICSI, are low, a small increased risk of borderline ovarian tumours cannot be excluded. [2013]

Inform people who are considering IVF treatment that the absolute risks of long-term adverse outcomes in children born as result of IVF are low. [2013]

Limit drugs used for controlled ovarian stimulation in IVF treatment to the lowest effective dose and duration of use. [2013]